Please assess the completion status of the following clinical trial:

Trial Title: Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 36 weeks gestation~* 3 months corrected age~* appropriate for gestational age (AGA)~* admitted for surgical correction of congenital heart defects (single ventricle, tetralogy of Fallot, truncus and complex biventricular repairs)~* enteral nutrition at 30 kcal/kilogram/day~Exclusion Criteria:~* 5 minute Apgar score of 4~* major congenital defect other than heart defect~* presence of significant neonatal morbidity (intraventricular hemorrhage (IVH) grade 3 or greater, necrotizing enterocolitis (NEC) and surgical abdomen)~* any metabolic disorder~* any endocrine disorder~* medications which alter eicosanoid metabolism including indomethacin, acetylsalicylate (with exception of steroids which will be analyzed independently)

- Gender: ALL
- Minimum Age: None
- Maximum Age: 3 Months
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).